COLRUYT/ BE0974256852 /
07/05/2024 16:54:37 | Var. - | Volume | Denaro12:49:21 | Lettera12:49:21 | Capitalizzazione di mercato | Dividend Y. | Rapporto P/E |
---|---|---|---|---|---|---|---|
42.16EUR | - | 216 Fatturato: 9,105.84 |
42.84Quantità in denaro: 400 | 42.92Quantità in lettera: 400 | 5.47 bill.EUR | 1.87% | 27.22 |
GlobeNewswire
12:45
Compass Pathways Announces First Quarter 2024 Financial Results and Business Highlights
GlobeNewswire
12:40
Cellectar Biosciences to Present at the Guggenheim Healthcare Talks Radiopharmaceuticals Day
GlobeNewswire
12:36
Temenos Multifonds extends partnership with Citi Securities Services to consolidate global funds ser...
GlobeNewswire
12:30
Veru Reports Fiscal 2024 Second Quarter Financial Results and Progress of its Enobosarm High Quality...
GlobeNewswire
12:30
Beam Therapeutics to Participate in RBC Capital Markets 2024 Global Healthcare Conference
GlobeNewswire
12:30
Compass Pathways announces durable improvement in symptoms through 12 weeks in open-label phase 2 st...
GlobeNewswire
12:15
Taboola Q1 2024 Results Beat High End of Guidance; Reiterates 2024 Guidance and Expects Accelerating...
GlobeNewswire
12:00
Latest DB-OTO Results Show Dramatically Improved Hearing to Normal Levels in a Child with Profound G...